Market revenue in 2023 | USD 153.7 million |
Market revenue in 2030 | USD 251.3 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | Modified/ attenuated live |
Fastest growing segment | Other Vaccines |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines |
Key market players worldwide | Boehringer Ingelheim, Zoetis, Merck & Co Inc, Indian Immunologicals, Elanco Animal Health Inc, Virbac SA, Ceva Santé Animale |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ruminant vaccines market will help companies and investors design strategic landscapes.
Modified/ attenuated live was the largest segment with a revenue share of 51.4% in . Horizon Databook has segmented the Spain ruminant vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines covering the revenue growth of each sub-segment from to .
Horizon Databook provides a detailed overview of country-level data and insights on the Spain ruminant vaccines market , including forecasts for subscribers. This country databook contains high-level insights into Spain ruminant vaccines market from to , including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account